Donald Haverkamp, MPH
Donald Haverkamp, MPH, is an epidemiologist in the Epidemiology and Applied Research Branch of the Division of Cancer Prevention and Control. He joined the Centers for Disease Control and Prevention as a Public Health Prevention Service fellow in 2004. Mr. Haverkamp is a field assignee in New Mexico, where he collaborates with the Indian Health Service Division of Epidemiology and Disease Prevention and various tribal organizations, implementing strategies and projects designed to increase colorectal cancer screening among American Indian and Alaska Native people. Mr. Haverkamp also has in interest in global health, and has deployed on temporary-duty assignments for CDC in Papua New Guinea (Stop Transmission of Polio team), Namibia (President’s Emergency Plan for AIDS Relief [PEPFAR]-related), The Gambia (Ebola response), Angola (yellow fever response), and Mozambique (polio outbreak response).
In some previous public health roles, Mr. Haverkamp supervised a team of communicable disease investigators at the San Diego County Health and Human Services Agency’s Tuberculosis Control Unit, and worked as a pediatric tuberculosis investigator at the University of California, San Diego. He also served as a United States Peace Corps volunteer (community health) in the Dominican Republic.
Mr. Haverkamp earned his Bachelor of Science degree in Health Science/Community Health Education from San Diego State University and a Master of Public Health degree with a concentration in epidemiology from the Graduate School of Public Health at San Diego State University.
Recent articles Mr. Haverkamp has coauthored include—
- 2022 Cancer disparities among non-Hispanic urban American Indian and Alaska Native populations in the United States, 1999–2017.
- 2021 Growing disparity in the incidence of colorectal cancer among non-Hispanic American Indian and Alaska Native populations—United States, 2013–2017.
- 2021 Incidence of and trends in the leading cancers with elevated incidence among American Indian and Alaska Native populations, 2012–2016.
- 2020 Gastric cancer among American Indian and Alaska Native populations in the United States, 2005–2016.
- 2020 Effectiveness of interventions to increase colorectal cancer screening among American Indians and Alaska Natives.
- 2019 Disparities in cancer incidence and trends among American Indians and Alaska Natives in the United States, 2010–2015.
- 2018 Incidence of primary liver cancer in American Indians and Alaska Natives, US, 1999–2009.
- 2016 Influences and practices in colorectal cancer screening among health care providers serving Northern Plains American Indians, 2011–2012.
- 2016 Causes and disparities in death rates among urban American Indian and Alaska Native populations, 1999–2009.
- 2016 A process evaluation of the Alaska Native Colorectal Cancer Family Outreach Program.
- 2014 Comparison of fecal occult blood tests for colorectal cancer screening in an Alaska Native population with high prevalence of Helicobacter pylori Infection, 2008–2012.
- 2014 Geographic variation in colorectal cancer incidence and mortality, age of onset, and stage at diagnosis among American Indian and Alaska Native people, 1990–2009.
- 2014 Methods for improving the quality and completeness of mortality data for American Indians and Alaska Natives.
- 2014 Leading causes of death and all-cause mortality in American Indians and Alaska Natives.
- 2011 A survey of Indian Health Service and tribal health providers’ colorectal cancer screening knowledge, perceptions, and practices.